A Comparison of Three Commercial Oral Rehydration Solutions Consumed After Extra-cellular Dehydration

Sponsor
Loughborough University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05775055
Collaborator
entrinsic bioscience LLC (Other)
16
1
3
7.1
2.3

Study Details

Study Description

Brief Summary

Dehydration is commonplace in a number of settings, including exercise, daily living (i.e. inadequate fluid intake) and with relatively common bacterial/viral infections that induce diarrhoea and/or vomiting. As such, it is important to develop effective strategies to facilitate the recovery and maintenance of body water (i.e. rehydration). Whilst rehydration from exercise dehydration has been well-studied, rehydration from other types of dehydration have not. Despite this, oral rehydration solutions have been produced and are commercially available (in chemists/pharmacies and supermarkets) to help recover from dehydration produced by illnesses like diarrhoea and vomiting. Most commercially available oral rehydration solutions use a sugar-base (glucose) and a mixture of electrolytes, but little work has gone into evaluating the efficacy of such solutions. Furthermore, more recent work has explored the use of proteins that they may offer some advantage over sugar/glucose-based beverages.

Therefore, the aim of this study is to investigate the efficacy of a protein-based oral rehydration solution compared to two current commercially available glucose-based oral rehydration solutions.

Condition or Disease Intervention/Treatment Phase
  • Other: Composition of oral rehydration solutions
N/A

Detailed Description

Dehydration refers to a decrease in body water and occurs when water losses in urine, sweat or other body fluid secretions (e.g vomit or diarrhoea) exceed fluid intake in drinks and foods. Indeed, dehydration is commonplace in a number of settings, including exercise, daily living (i.e. inadequate fluid intake) and with relatively common bacterial/viral infections that induce diarrhoea and/or vomiting. As such it is important to develop effective strategies to facilitate the recovery and maintenance of body water (i.e. rehydration).

Whilst rehydration from exercise dehydration has been well-studied, rehydration from other types of dehydration have not. Despite this, oral rehydration solutions have been produced and are commercially available (in chemists/pharmacies and supermarkets) to help recover from dehydration produced by illnesses like diarrhoea and vomiting. Oral rehydration solutions have been developed that vary in their composition for both electrolytes and other nutrients (glucose, amino acids etc.). Most commercially available oral rehydration solutions use a sugar-base (glucose) and a mixture of electrolytes, but little work has gone into evaluating the efficacy of such solutions. Furthermore, more recent work has explored the use of amino acids (the building blocks of proteins) in isolation or as complete proteins and suggest that they may offer some advantage over sugar/glucose-based beverages.

Dehydration produced by illnesses like diarrhoea and vomiting cause water an electrolyte losses that are different in nature to exercise and as such, exercise is not a good way to study these effects. The type of dehydration produced with diarrhoea and vomiting can be mimicked by using a diuretic like furosemide. This type of diuretic is used clinically in situations of water overload (e.g. congestive heart failure or high blood pressure) and are used daily for months in many patients. They produce mild dehydration (~2-2.5%) and thus offer the opportunity to understand recovery from the type of dehydration caused by illness, without the presence of illness.

Given the body water contains high amounts of salts (electrolyte), when dehydration occurs electrolytes are also lost from the body. These electrolytes are needed to retain water in the various spaces of the body (inside cells, in the blood etc.) and thus failure to replace the electrolytes lost during dehydration will lead to a less effective rehydration response. Therefore, commercial oral rehydration solutions contain a balance of different electrolytes to replace those lost with dehydration and to help retain the ingested fluid. However, different formulations use a different balance of electrolytes and little work has examined the efficacy of these different formulations.

Therefore there is a need to understand the efficacy of different oral rehydration solution formulations following dehydration, something that has received little attention to date, surprisingly. Therefore, this study will compare the rehydration efficacy of a commercial amino-acid based oral rehydration solution compared to two current commercially available glucose-based oral rehydration solutions after dehydration induced by a diuretic.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Double-blind, randomised, crossover designDouble-blind, randomised, crossover design
Masking:
Double (Participant, Investigator)
Masking Description:
Double-blind
Primary Purpose:
Basic Science
Official Title:
A Comparison of Three Commercial Oral Rehydration Solutions Consumed After Extra-cellular Dehydration
Anticipated Study Start Date :
Mar 14, 2023
Anticipated Primary Completion Date :
Oct 15, 2023
Anticipated Study Completion Date :
Oct 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Commercially Available Oral Rehydration Solution A

A commercially available oral rehydration solution (~2.8% carbohydrate, ~45 mmol/L sodium, ~20 mmol/L potassium, 34 mmol/L chloride)

Other: Composition of oral rehydration solutions
Investigate the efficacy of an amino acid-based oral rehydration solution compared to two current commercially available glucose-based oral rehydration solutions.

Experimental: Commercially Available Oral Rehydration Solution B

A commercially available oral rehydration solution (~0.1% carbohydrate, ~2% amino acids (protein), ~67 mmol/L sodium, ~20 mmol/L potassium, 30 mmol/L chloride)

Other: Composition of oral rehydration solutions
Investigate the efficacy of an amino acid-based oral rehydration solution compared to two current commercially available glucose-based oral rehydration solutions.

Experimental: Commercially Available Oral Rehydration Solution C

A commercially available oral rehydration solution (~2.2% carbohydrate, ~45 mmol/L sodium, ~20 mmol/L potassium)

Other: Composition of oral rehydration solutions
Investigate the efficacy of an amino acid-based oral rehydration solution compared to two current commercially available glucose-based oral rehydration solutions.

Outcome Measures

Primary Outcome Measures

  1. Net fluid balance [9 hours]

    Determined from urine output and drink volume collected before and after drink ingestion

  2. Drink retention [4 hours]

    Determined from urine output and drink volume collected before and after drink ingestion

  3. Electrolyte balance [9 hours]

    Determined from electrolyte concentrations (i.e., sodium, potassium, chloride) in urine and drink samples before and after drink ingestion

  4. Speed of rehydration [4 hours]

    Determined from urine output and drink volume collected before and after drink ingestion

Secondary Outcome Measures

  1. Plasma volume [9 hours]

    Determined from haemoglobin and haematocrit measures in blood samples collected before and after drink ingestion

  2. Plasma osmolality [9 hours]

    Determined from venous blood samples collected before and after drink ingestion

  3. Urine volume [9 hours]

    Determined from urine samples collected before and after drink ingestion

  4. Urine electrolyte concentration (i.e., sodium, potassium, chloride) [9 hours]

    Determined from urine samples collected before and after drink ingestion

  5. Blood electrolyte concentration (i.e., sodium, potassium, chloride) [9 hours]

    Determined from blood samples collected before and after drink ingestion

  6. Body mass change [9 hours]

    Determined from weighing participants before and after drink ingestion

  7. Urine specific gravity [9 hours]

    Determined from urine samples collected before and after drink ingestion

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-45 years of age

  • male or female

  • good health

Exclusion Criteria:
  • Gastrointestinal, cardiovascular or renal conditions; other health conditions that might influence the study outcomes.

  • Medication use (e.g. anti-biotics, diuretics, NSAIDS etc.) that might influence the study outcomes or interact with furosemide.

  • Allergy to sulfonamides (sulfa drugs).

  • Smoking (including vaping)

  • Amenorrhoeic females

  • Any high-level/elite athlete, or aspiring high level athlete, where drug testing/regulations are carried out and regulations need to be followed (furosemide is prohibited in sport as it is used as a masking agent).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Loughborough University Loughborough Leicestershire United Kingdom LE11 3TU

Sponsors and Collaborators

  • Loughborough University
  • entrinsic bioscience LLC

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lewis James, Reader in Nutrition, Loughborough University
ClinicalTrials.gov Identifier:
NCT05775055
Other Study ID Numbers:
  • LEON8472
First Posted:
Mar 20, 2023
Last Update Posted:
Mar 20, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2023